Search

everythinglearnresearchcommunity

for

Search:↓

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Minoxidil keeps most hair growth from first year and twice-daily use is better with few side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.